Related Experiment Video
Updated: Jul 15, 2026

Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration
Published on: May 26, 2023
Age-related macular degeneration: the costs to society and the patient
Omesh P Gupta1, Gary C Brown, Melissa M Brown
1Retina Service, Wills Eye at Thomas Jefferson University, Philadelphia, USA. ogupta@hotmail.com
Purpose Of Review:
The current literature was reviewed to assess the patient and societal costs associated with age-related macular degeneration (ARMD).
Recent Findings:
An increasing number of studies discuss the growing direct ophthalmologic, direct nonophthalmologic, and indirect costs associated with ARMD. Most reports, however, focus on only one of these aspects. The prevalence of this debilitating disease will increase as life expectancy increases.
Summary:
ARMD continues to be a major public health problem in developed countries. The treatment and management of exudative ARMD are changing dramatically. These therapies will likely become a more significant portion of the overall healthcare burden of ARMD. To date, no comprehensive study exists that attempts to calculate the total cost of ARMD.
More Related Videos
09:24A Protocol to Evaluate and Quantify Retinal Pigmented Epithelium Pathologies in Mouse Models of Age-Related Macular Degeneration
Published on: March 10, 2023
08:54A Workflow to Quantitatively Determine Age-Related Macular Degeneration Lesion-Specific Variations in Fundus Autofluorescence
Published on: May 26, 2023
Related Concept Videos
Diabetic Retinopathy
iPS Cell Differentiation
Photoreceptors and Visual Pathways
Glaucoma: Overview